24 Oct 2017 | 1:14 AM
 

Aurobindo Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524804 | NSE Symbol: AUROPHARMA
750.50
-3.30
(-0.43 %)
23 Oct 2017 | 03:44 PM
Change company
  • Open (Rs)
    765.00
  • Prev. close (Rs.)
    753.80
  • High (Rs.)
    767.00
  • Low (Rs.)
    745.00
  • 52W H (Rs.)
    831.00
  • 52W L (Rs.)
    504.00
  • Volume
    92993
  • MCap (Rs in Cr.)
    43,970.45
751.5
-4.05
(-0.54 %)
  • Open (Rs)
    761.00
  • High (Rs)
    767.90
  • Low (Rs)
    744.25
  • Prev. close(Rs)
    755.55
  • Contracts Tra.
    68,18,400
  • Turnover (Cr.)
    514
  • Open Interest
    1,64,94,400
  • Open Int. chg
    1,64,70,400.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
39.29
Operating Margin (%)
23.03
Gross Profit Margin (%)
20.16
Net Profit Margin (%)
15.43
Total Debt/Equity
0.33
Dividend payout Ratio (Net Profit)
5.96
Earning Retention Ratio
94.02

News

17 Oct 2017 - 11:01:00-Leading pharma major Aurobindo Pharma Limited has said that the company has received final approval ...
21 Aug 2017 - 10:21:00-Leading pharma major Aurobindo Pharma Limited has said that it has received tentative approval from ...
10 Aug 2017 - 11:54:00-Pharma major Aurobindo Pharma said that it is planning to increase its stake in Tergene Biotech whic...
10 Aug 2017 - 11:54:00-Pharma major Aurobindo Pharma said that it is planning to increase its stake in Tergene Biotech whic...

Announcements

17-Oct-2017
Aurobindo Pharma - Press Release
17-Oct-2017
Aurobindo Pharma - Press Release / Media Release
12-Oct-2017
Aurobindo Pharma - Compliance Certificate For The Half Year Ended 30.09.2017
12-Oct-2017
Aurobindo Pharma - Statement Of Investor Complaints For The Quarter Ended 30.09.2017
06-Oct-2017
Aurobindo Pharma - Compliance Certificate Under Regulation 40(9) For The Half Year Ended 30.09.2017

Religare Research

23 Oct 2017 | 07:25 PM
• Gold prices rebounded from two month lows on Friday as fresh concerns over tensions with North Kor...
23 Oct 2017 | 06:30 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
23 Oct 2017 | 10:46 AM
Indian rupee closed little changed with marginal losses against the US dollar as traders avoided tak...
23 Oct 2017 | 09:33 AM
Gold dipped as dollar gained after US Senate cleared tax reform hurdle  Crude oil rose on tighter f...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
94,96,996 715.12 55.31 -0.81
94,96,996 715.12 589.06 -0.81
94,96,996 715.12 611.34 -0.80
94,96,996 715.12 57.91 -0.80
48,31,294 363.80 449.44 -0.52

Shareholding Pattern

       
Promotors51.87%
Mutual Funds/UTI14.89%
FI/Banks0.46%
Insurance0.46%
FII18.80%
Government0.00%
Others4.32%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,731.00(-1.54)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,456.60(0.96)
3317
 Dr. Reddy`s Laboratories Ltd.
2,364.85(-0.32)
3294
 Alkem Laboratories Ltd.
1,864.00(1.42)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Aurobindo Pharma Ltd.47.95-0.40122.50
NIFTY(S&P CNX)312.25220.30966.90
BSE SENSEX880.09260.852,850.88
BSE 500522.15422.321,344.29

Corporate Details

Key Personal
Avnit Bimal Singh
Non Exe. & Ind. Director
D Rajagopala Reddy
Non Exe. & Ind. Director
K Nithyananda Reddy
Vice Chairman & Whole Time Dir
Key Address
Registered Office
Plot No.2 Maitri Vihar Ameerpet,Hyderabad,Telangana

Tel:040-23736370 66725000, Fax:040-23747340 67074059

info@aurobindo.com
http://www.aurobindo.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda